time
Maxine Gowen – Top 10 Women in Biotech
Name: Maxine Gowen Current Company: Trevena Title: President & CEO Profile:
Daphne Zohar – Top 10 Women in Biotech
Name: Daphne Zohar Current Company: PureTech Ventures Title: Founder, Managing Partner Profile: Daphne Zohar is the founder and managing partner of Boston-based venture capital firm PureTech Ventures. A serial entrepreneur, she was the founding CEO at four biotech companies: Follica, Libra Biosciences, Karuna Pharmaceuticals and Satori Pharmaceuticals.
Boutique, primary care at a price
Since 2004, the primary care physicians at Tufts Medical Center have offered patients the option of being part of either a traditional general medical practice or a retainer practice.
GSK’s Response to the Sirtuin Critics
OK, time (finally) for the latest chapter in the GSK-Sirtris saga. (This is going to get fairly geeky, so feel free to skip ahead if you’re not into enzymology).
The barriers to digital pharma marketing
According to a Harris Poll pharma is the 2nd most least trustworthy advertising behind financial service companies. Of course you would never know this by watching the network news where most of the TV spots are still from pharma. Why is this continuing to go on when so much data says that the ROI of TV ads is really poor ? Here are some reasons… 1. We’re going to play it safe: It’s safer and easier to do what is already being done than to try new things even if the market has changed
71% of physicians said that a smartphone is essential to their practice
Smartphones are becoming more essential to physicians but it may not be because of Internet connections. The recent research I conducted with physicians showed that in fact physicians were using smartphone applications a lot more than the Internet for professional purposes. When asked why most said “the Internet connections are too slow”.
Can Eli Lilly get its R&D act together?
Eli Lilly’s recent late-stage pratfall in Alzheimer’s set the stage for a blistering Fortune piece dissecting the yawning gap between the Big Pharma’s R&D game plan and its woeful
What pharma should be doing now: A strategic approach
As a former Lilly marketer I am really sad to see what is happening to them.
Making patients more responsible for their health
Richard Reece is the author of Obama, Doctors, and Health Reform recently made this statement in a guest post article at Kevin MD ; The surest way to reduce costs is having patients spend more of their own money and making them more responsible for their health, which is the premise of lower- premium health savings accounts and high deductible plans. This is an excellent point and it has to be driven home because as a nation we cannot afford to pay medical costs for people who live unhealthy lifestyles and refuse to make any attempt to modify their lifestyle to improve their health. Time is the new currency for most consumers.
Not The End. Not At All
All right, given the way things have been going the last few years, it’s easy to wonder if there’s a place for medicinal chemistry at all – even if there’s a place for drug discovery.





